We are thrilled to announce the release of the second edition of Pharma Focus America magazine for 2023!
Navigating the complex and dynamic gene therapy regulatory landscape has been a persistent challenge for developers and manufacturers.
The pharmaceutical industry operates in a constantly shifting regulatory environment. Health authorities worldwide are continually updating and revising regulations
Antibody drug conjugates (ADCs) are innovative modalities to deliver chemotherapeutics to specifically targeted populations of cancer cells.
The macroeconomic fundamentals of the pharmaceutical industry remain strong.
The first challenge when implementing digital health technologies is achieving the adoption and acceptance of digital biomarkers
Clinical trials form the backbone of pharmaceutical development, acting as the proving ground where the safety and efficacy of novel medical interventions are thoroughly evaluated.
Although genes encode cellular functions and fates, with DNA acting as an inert cookbook, metabolism is the lifeblood of every living cell.
A number of exciting innovations have begun to gain the attention of companies within the pharmaceutical sector. Artificial intelligence (AI)
eBR systems are more reliable and compliance than traditional paper documents, log in measures,
Emerging technologies are technologies that are in the early stages of adoption in drug substance and drug product development
In this panel discussion, our panelists will explore how big data analytics is reshaping drug discovery, clinical trials, patient care, and regulatory decisions.
Antibody humanization and affinity maturation have revolutionized the biotech industry in the past 10–20 years
